Rapid Micro Biosystems Q4 commercial revenue $4.4M, FY2022 $17.1M; guides FY2023 at least $22M

RAPID MICRO BIOSYSTEMS, INC.

Q4 2022 commercial revenue $4.4M (vs $4.9M prior year); net loss $16.4M ($0.39 per share).
Full year 2022 commercial revenue $17.1M (vs $21.6M prior year); net loss $60.8M ($1.43 per share).
Recurring commercial revenue grew 28% in Q4 to $2.9M; full year recurring revenue $11.0M (+40% YoY).
Placed 2 new systems in Q4, 9 in full year; cumulative 125 placed, 103 validated systems.
FY2023 guidance: commercial revenue at least $22M, with at least 15 new system placements.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

RAPID MICRO BIOSYSTEMS, INC. reported the fourth quarter ended December 31, 2022 results: revenue $4.4 million, net income $16.4 million, EPS $0.39.

Period: the fourth quarter ended December 31, 2022
Revenue: $4.4 million
Net income: $16.4 million
EPS: $0.39
Result: reported results

Exact text from the filing

Total revenue for the fourth quarter of 2022 was $4.4 million, compared to $5.2 million in the fourth quarter of 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

RAPID MICRO BIOSYSTEMS, INC. reported the fiscal year ended December 31, 2022 results: revenue $17.1 million, net income $60.8 million, EPS $1.43.

Period: the fiscal year ended December 31, 2022
Revenue: $17.1 million
Net income: $60.8 million
EPS: $1.43
Result: reported results

Exact text from the filing

Total revenue for the full year was $17.1 million in 2022, compared to $23.2 million in 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

RAPID MICRO BIOSYSTEMS, INC. reported full year 2023 results: revenue at least $22.0 million. Guidance initiated.

Period: full year 2023
Revenue: at least $22.0 million
Guidance: initiated
Result: guidance update

Exact text from the filing

For the full year 2023, the Company expects commercial revenue of at least $22.0 million, including the placement of at least 15 new systems.

View on SEC.gov

41 earnings releases filed in the last 30 days. Browse all earnings releases →

RAPID MICRO BIOSYSTEMS, INC. filing history →

Source: SEC EDGAR

accession 0001380106-23-000011

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.